
Neil P. Hammell
Examiner (ID: 9948, Phone: (571)270-5919 , Office: P/1636 )
| Most Active Art Unit | 1636 |
| Art Unit(s) | 1636, 1634 |
| Total Applications | 484 |
| Issued Applications | 164 |
| Pending Applications | 50 |
| Abandoned Applications | 284 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15513291
[patent_doc_number] => 10563223
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-18
[patent_title] => Intergenic elements for enhancing gene expression
[patent_app_type] => utility
[patent_app_number] => 15/720116
[patent_app_country] => US
[patent_app_date] => 2017-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 18726
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 230
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15720116
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/720116 | Intergenic elements for enhancing gene expression | Sep 28, 2017 | Issued |
Array
(
[id] => 12660412
[patent_doc_number] => 20180111970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-26
[patent_title] => LONG UNIFORM RECOMBINANT PROTEIN FIBERS
[patent_app_type] => utility
[patent_app_number] => 15/705185
[patent_app_country] => US
[patent_app_date] => 2017-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26037
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15705185
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/705185 | Long uniform recombinant protein fibers | Sep 13, 2017 | Issued |
Array
(
[id] => 17287218
[patent_doc_number] => 11203759
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-21
[patent_title] => Oxygen-responsive bacterial gene switch
[patent_app_type] => utility
[patent_app_number] => 15/698302
[patent_app_country] => US
[patent_app_date] => 2017-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10664
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 191
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15698302
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/698302 | Oxygen-responsive bacterial gene switch | Sep 6, 2017 | Issued |
Array
(
[id] => 12663847
[patent_doc_number] => 20180113115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-26
[patent_title] => SCREENING ASSAYS BASED ON MAG AND/OR ABHD6 FOR SELECTING INSULIN SECRETION PROMOTING AGENT
[patent_app_type] => utility
[patent_app_number] => 15/693824
[patent_app_country] => US
[patent_app_date] => 2017-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19976
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 324
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15693824
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/693824 | SCREENING ASSAYS BASED ON MAG AND/OR ABHD6 FOR SELECTING INSULIN SECRETION PROMOTING AGENT | Aug 31, 2017 | Abandoned |
Array
(
[id] => 13690177
[patent_doc_number] => 20170356043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-14
[patent_title] => ACTIVITY-DEPENDENT GENE PAIRS AS THERAPEUTIC TARGETS AND METHODS AND DEVICES TO IDENTIFY THE SAME
[patent_app_type] => utility
[patent_app_number] => 15/684845
[patent_app_country] => US
[patent_app_date] => 2017-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12063
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15684845
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/684845 | ACTIVITY-DEPENDENT GENE PAIRS AS THERAPEUTIC TARGETS AND METHODS AND DEVICES TO IDENTIFY THE SAME | Aug 22, 2017 | Abandoned |
Array
(
[id] => 16925265
[patent_doc_number] => 11046727
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-29
[patent_title] => Methods for isolation, identification, and quantification of miRNAs
[patent_app_type] => utility
[patent_app_number] => 15/682103
[patent_app_country] => US
[patent_app_date] => 2017-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 22
[patent_no_of_words] => 11813
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 191
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15682103
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/682103 | Methods for isolation, identification, and quantification of miRNAs | Aug 20, 2017 | Issued |
Array
(
[id] => 12206121
[patent_doc_number] => 20180051348
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-22
[patent_title] => 'PREDICTION OF LIKELIHOOD OF CANCER RECURRENCE'
[patent_app_type] => utility
[patent_app_number] => 15/674817
[patent_app_country] => US
[patent_app_date] => 2017-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12689
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15674817
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/674817 | Prediction of likelihood of cancer recurrence | Aug 10, 2017 | Issued |
Array
(
[id] => 12409278
[patent_doc_number] => 09970026
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-15
[patent_title] => Compositions and methods of engineered CRISPR-Cas9 systems using split-nexus Cas9-associated polynucleotides
[patent_app_type] => utility
[patent_app_number] => 15/665155
[patent_app_country] => US
[patent_app_date] => 2017-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 27
[patent_no_of_words] => 53642
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 306
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15665155
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/665155 | Compositions and methods of engineered CRISPR-Cas9 systems using split-nexus Cas9-associated polynucleotides | Jul 30, 2017 | Issued |
Array
(
[id] => 12409281
[patent_doc_number] => 09970027
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-15
[patent_title] => Compositions and methods of engineered CRISPR-CAS9 systems using split-nexus CAS9-associated polynucleotides
[patent_app_type] => utility
[patent_app_number] => 15/665201
[patent_app_country] => US
[patent_app_date] => 2017-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 27
[patent_no_of_words] => 53705
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15665201
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/665201 | Compositions and methods of engineered CRISPR-CAS9 systems using split-nexus CAS9-associated polynucleotides | Jul 30, 2017 | Issued |
Array
(
[id] => 13609697
[patent_doc_number] => 20180356398
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-13
[patent_title] => LIVING TISSUE MODEL DEVICE, VASCULAR WALL MODEL, VASCULAR WALL MODEL DEVICE AND METHOD OF EVALUATING TEST SUBSTANCE
[patent_app_type] => utility
[patent_app_number] => 15/618150
[patent_app_country] => US
[patent_app_date] => 2017-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15665
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15618150
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/618150 | LIVING TISSUE MODEL DEVICE, VASCULAR WALL MODEL, VASCULAR WALL MODEL DEVICE AND METHOD OF EVALUATING TEST SUBSTANCE | Jun 8, 2017 | Abandoned |
Array
(
[id] => 11971541
[patent_doc_number] => 20170275695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-28
[patent_title] => 'METHODS AND SYSTEMS FOR MONITORING, DIAGNOSING, AND TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE'
[patent_app_type] => utility
[patent_app_number] => 15/618075
[patent_app_country] => US
[patent_app_date] => 2017-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 32707
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15618075
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/618075 | Methods and systems for monitoring, diagnosing, and treating chronic obstructive pulmonary disease | Jun 7, 2017 | Issued |
Array
(
[id] => 12641199
[patent_doc_number] => 20180105564
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-19
[patent_title] => USE OF ENDOGENOUS PROMOTERS TO EXPRESS HETEROLOGOUS PROTEINS
[patent_app_type] => utility
[patent_app_number] => 15/609983
[patent_app_country] => US
[patent_app_date] => 2017-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10144
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15609983
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/609983 | USE OF ENDOGENOUS PROMOTERS TO EXPRESS HETEROLOGOUS PROTEINS | May 30, 2017 | Abandoned |
Array
(
[id] => 13703269
[patent_doc_number] => 20170362589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => DE NOVO SYNTHESIZED GENE LIBRARIES
[patent_app_type] => utility
[patent_app_number] => 15/603013
[patent_app_country] => US
[patent_app_date] => 2017-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 115997
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15603013
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/603013 | DE NOVO SYNTHESIZED GENE LIBRARIES | May 22, 2017 | Abandoned |
| 15/600305 | Protection of Cells from Degeneration and Treatment of Geographic Atrophy | May 18, 2017 | Abandoned |
Array
(
[id] => 13888305
[patent_doc_number] => 10196698
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-05
[patent_title] => DNA methylation markers for metastatic prostate cancer
[patent_app_type] => utility
[patent_app_number] => 15/598684
[patent_app_country] => US
[patent_app_date] => 2017-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 43
[patent_no_of_words] => 22327
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15598684
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/598684 | DNA methylation markers for metastatic prostate cancer | May 17, 2017 | Issued |
Array
(
[id] => 17045166
[patent_doc_number] => 11098335
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-24
[patent_title] => Expression system
[patent_app_type] => utility
[patent_app_number] => 15/588851
[patent_app_country] => US
[patent_app_date] => 2017-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 18
[patent_no_of_words] => 10602
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15588851
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/588851 | Expression system | May 7, 2017 | Issued |
Array
(
[id] => 11942474
[patent_doc_number] => 20170246625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'GENETIC SAMPLE COLLECTION SYSTEMS'
[patent_app_type] => utility
[patent_app_number] => 15/491248
[patent_app_country] => US
[patent_app_date] => 2017-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8232
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15491248
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/491248 | GENETIC SAMPLE COLLECTION SYSTEMS | Apr 18, 2017 | Abandoned |
Array
(
[id] => 12001799
[patent_doc_number] => 20170305955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'Reprogramming of Cellular Adhesion'
[patent_app_type] => utility
[patent_app_number] => 15/482591
[patent_app_country] => US
[patent_app_date] => 2017-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 54
[patent_no_of_words] => 24875
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15482591
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/482591 | Reprogramming of cellular adhesion | Apr 6, 2017 | Issued |
Array
(
[id] => 11866522
[patent_doc_number] => 20170233807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-17
[patent_title] => 'Epigenetic Markers for the Identification of Blood Sub-cells of Type 1'
[patent_app_type] => utility
[patent_app_number] => 15/477768
[patent_app_country] => US
[patent_app_date] => 2017-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 7570
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15477768
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/477768 | Epigenetic Markers for the Identification of Blood Sub-cells of Type 1 | Apr 2, 2017 | Abandoned |
Array
(
[id] => 13703379
[patent_doc_number] => 20170362644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => METHODS AND COMPOSITIONS FOR DETECTING A TARGET RNA
[patent_app_type] => utility
[patent_app_number] => 15/467922
[patent_app_country] => US
[patent_app_date] => 2017-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 77152
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15467922
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/467922 | Methods and compositions for detecting a target RNA | Mar 22, 2017 | Issued |